Patient services programs and the associated risks across the life sciences industry vary in shape and style, especially as the government is beginning to heavily investigate the activities conducted by manufacturers in this area. This article highlights some of the differences in the industry as seen through an annual patient services compliance survey conducted by Helio Health Group.
By Minna Bak, Senior Manager, Marci Juneau, Partner, and Manny Tzavlakis, Managing Partner, Helio Health Group
To read the complete article click the link to Policy and Medicine Compliance Update February 2019 issue